Lacosamide Tablet, Film Coated
Product Images NDC 70518-4689

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70518-4689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Lacosamide 50mg 70518 4689 00)

This is a description of Lacosamide tablet C-V, with a strength of 50 mg. Each box contains 30 tablets, with the NDC number 70518-4689-00. The medication is in pink color and manufactured by Ascend Labs, LLC. It is only for prescription use and should not be transferred to anyone other than the prescribed patient. The medication is repackaged by RemedyRepack Inc., and should be stored at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Lacosamide Tablet C-V 50 mg, with details such as quantity, NDC number, and manufacturer information. The text includes cautionary information regarding the transfer of the drug, storage instructions, and contact information for the repackager. It also provides guidance on the usual dosage and where to keep the medication to ensure it is out of reach of children.*

FDA Label Image

Laco-fig1.jpg (Laco Fig1)

The provided text is from a figure showing the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose. The figure includes data for different studies labeled as "Stuy 2," "Stuy 3," and "Stuy 4." The doses mentioned in the figure are 200mg, 400mg, and 600mg for Lacosamide. It also indicates statistical significance when comparing to a placebo.*

FDA Label Image

Laco-fig2.jpg (Laco Fig2)

This information depicts the Responder Rate for Lacosamide compared to a Placebo in Studies 2, 3, and 4. The figure shows the proportion of patients falling under different Responder Rates, with Lacosamide dosages of 200mg/day, 400mg/day, and 600mg/day included for comparison. This data can be valuable for assessing the efficacy of Lacosamide in treating certain conditions.*

FDA Label Image

Laco-fig3-a (Laco Fig3 A)

The text shows information related to a study or analysis involving a medication called Lacosamide. It includes data on the proportion of patients treated with Lacosamide, with specific values and statistical indicators such as a p-value, HR (Hazard Ratio), risk reduction percentage, and confidence interval. The text also displays a graph or table showing the number of patients at risk over time.*

FDA Label Image

Laco-str (Laco Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.